Protective and therapeutic effects of Lactobacillus brevis PQ214320 and Bacillus subtilis PQ198038 Against experimental Trichinella Infection
Fig 8
All the intestinal (a,b) and muscular (c,d) Picrosirius red and Claudin 1 expression values are expressed as the mean ± SD (n = 5, 10 random fields per each one).
C: Positive Trichinella untreated control mice, ALB: Infected mice treated with albendazole, BS: Infected mice post-treated with B. subtilis PQ198038, BSP: Infected mice pre-treated with B. subtilis PQ198038 before of infection and continued after infection, L: Infected mice post-treated with L. brevis PQ214320, LP: Infected mice pre-treated with L. brevis PQ214320 before of infection and continued after infection. The significant (P < 0.01) differences are (a) compared to the C group, (b) against the ALB group, (c) compared with the BS group, (d) compared with the BSP group, and (e) compared with L group. The significant (P < 0.05) difference is (f) compared to the C group. The remaining groups representing insignificant difference relative to each other’s.